Suchergebnisse - "Alber, Hannes"

PubPharm (167)

1

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction : Insights from the International POPular Age Registry

enthalten in: Journal of clinical medicine | 2023

von van den Broek, W. | Gimbel, M. | Chan Pin Yin, D. | +27

2

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

enthalten in: Wiener klinische Wochenschrift | 2023

von Toplak, H. | Bilitou, A. | Alber, H. | +19

3

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

enthalten in: Wiener klinische Wochenschrift | 2023

von Toplak, H. | Bilitou, A. | Alber, H. | +19

4

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

enthalten in: Wiener klinische Wochenschrift | 2023

von Toplak, H. | Bilitou, A. | Alber, H. | +19

5

Empagliflozin in acute myocardial infarction : the EMMY trial

enthalten in: European heart journal | 2022

von von Lewinski, D. | Kolesnik, E. | Tripolt, N. | +22

CommentIn: Eur Heart J. 2022 Nov 1;43(41):4433-4435. - PMID 36036745

6

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

enthalten in: Circulation | 2022

von Rao, S. | Kirsch, B. | Bhatt, D. | +114

CommentIn: Circulation. 2022 Oct 18;146(16):1207-1209. - PMID 36030388

7

Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial

enthalten in: Journal of clinical medicine | 2022

von von Lewinski, D. | Benedikt, M. | Alber, H. | +12

8

Risk prediction models for discrete ordinal outcomes : Calibration and the impact of the proportional odds assumption

enthalten in: Statistics in medicine | 2022

von Edlinger, M. | van Smeden, M. | Alber, H. | +2

9

Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III study

enthalten in: American heart journal | 2022

von von Lewinski, D. | Tripolt, N. | Sourij, H. | +19

10

Risk prediction models for discrete ordinal outcomes : Calibration and the impact of the proportional odds assumption

enthalten in: Statistics in Medicine | 2022

von Edlinger, M. | Smeden, M. | Alber, H. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]